SERONO

Welcome to the Brand page for “SERONO”, which is offered here for In the statement, column 1, line 11, oncology should be deleted. in the statement, column 1, line 15, cardiovascular should be deleted. in the statement, column 2, line 1, circulatory diseases should be deleted. in the statement, column 2, lines 2 through 5, hematological disorders, calcium disorders, antiviral preparations for ophthalmic use should be deleted, and the drawing is amended to appear as follows: serono.;house mark for a full line of pharmaceutical preparations for use in the treatment of infertility and/or ovulation induction, immunology -- [oncology,] pediatrics and endocrinology, auto immune diseases, growth and metabolism, diseases of the central nervous system, cancer, [cardiovascular and circulatory diseases,] viral diseases, inflammatory and [hematological disorders, calcium disorders, antiviral preparations for opthalmic use];.

Its status is currently believed to be active. Its class is unavailable. “SERONO” is believed to be currently owned by “MERCK KGAA”.